Guthridge Joel

Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.

Pathways of impending disease flare in African-American systemic lupus erythematosus patients.

Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis.

Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.

Human effector B lymphocytes express ARID3a and secrete interferon alpha.

Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.